Date: Tuesday, February 22, 2022

Time: 6:00 PM-7:00 PM CT (may go to 7:30 PM depending on Q&A)

Location: Zoom

Did
you know: “Currently, more than 6 million people in the United States
live with Alzheimer’s disease. According to estimates, this number will
rise to more than 13 million by the year 2050.“ Source: MedicalNewsToday

 

Written by Mary McGorray, M.D. on January 14, 2022 — Fact checked by Ferdinand Lali, Ph.D.

If you are young, middle aged, or older: Should you be concerned?

Keeping
track of the state of Alzheimer’s disease research and clinical care
can prove both challenging and confusing. Dr. Russell H. Swerdlow, M.D.
will provide perspective on these topics, through a discussion of past
perceptions of Alzheimer’s disease, current views, and what the future
may hold.

About Dr. Swerdlow, MD
Dr. Russell Swerdlow,
M.D. is a professor in the Departments of Neurology, Molecular and
Integrative Physiology, and Biochemistry and Molecular Biology at the
University of Kansas School of Medicine. He directs the University of
Kansas Alzheimer’s Disease Research Center, its Neurodegenerative
Disorders Program, and the Heartland Center for Mitochondrial Medicine.
He received undergraduate and MD degrees from New York University, and
trained as a neurologist and Alzheimer’s specialist at the University of
Virginia. He holds the Gene and Marge Sweeney Chair at the University
of Kansas and is a recipient of an S. Weir Mitchell Award from the
American Academy of Neurology, a Cotzias Award from the American
Parkinson’s Disease Association, and a Chancellor’s Club Research Award
from the University of Kansas. From 2017-2021 he sat on the NIA Board of
Scientific Counselors. Dr. Swerdlow’s research focuses on brain energy
metabolism, its role in Alzheimer’s disease, and its therapeutic
manipulation.

 

Event questions: Marty Lustig `63

Registration questions: Cole Johnston
`20

 

Please adhere to the
Cornell
University guidelines in regards to COVID-19.